Name | Dihydrexidine hydrochloride |
---|
Description | Dihydrexidine hydrochloride (DAR-0100 hydrochloride) is a high potent, selective and full efficacy D1-like dopamine receptor (D1/D5) agonist, with an IC50 of 10 nM for D1 receptor. Dihydrexidine hydrochloride exhibits potent antiparkinsonian activity[1][2][3][4]. |
---|---|
Related Catalog | |
Target |
IC50: 10 nM (D1 dopamine receptor), D5 dopamine receptor, 660 nM (D2 dopamine receptor)[1] |
In Vivo | Dihydrexidine hydrochloride has poor oral bioavailability and a relatively short half-life of 1 to 2 h[3]. Dihydrexidine hydrochloride (3 mg/kg; i.p.) produces prominent dopamine D1 receptor agonist effects in vivo[4]. Animal Model: Adult male Sprague–Dawley rats (275-300 g)[4] Dosage: 3 mg/kg Administration: Intraperitoneal injection Result: Produces prominent dopamine D1 receptor agonist effects in vivo. |
References |
Molecular Formula | C17H18ClNO2 |
---|---|
Molecular Weight | 303.78 |